[Use of vildagliptin from an internal disease specialists point of view].
Dipeptidyl peptidase 4 inhibitors (DPP 4) are used as an oral hypoglycaemic agent in Type- 2 diabetic patients. From a clinical point of view the most important advantages of this preparation are improved diabetes compensation, significant reduction of hypoglycaemia risk compared with sulfonylurea derivatives, neutral weight profile and good GIT tolerance. Vildagliptin is a molecule from the group of DPP 4 inhibitors which is recently used in internal outpatient care.